Company

Apertor Pharmaceuticals

Biotechnology Research Alameda, California, United States 12 employees

Employees: 12
Contacts: 3
Emails: 3
Phones: 3

www.apertorpharma.com LinkedIn

Apertor Pharmaceuticals Overview

Headquarters: Alameda, California, United States
Website: www.apertorpharma.com
Industry: Biotechnology Research
Employees: 12
Founded: 2020
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Apertor Pharmaceuticals

At Apertor we have developed a new class of therapeutics to address one of the toughest challenges in drug discovery — selective disruption of disease-causing protein-protein interactions (PPIs). Apertor’s Interceptors are designed to selectively disrupt protein complexes via proximity induction by recruiting an abundantly expressed protein naturally found in cancerous cells patient’s own proteins to safely and effectively block PPIs . Using our synthetic biology platform technology to invent and develop proprietary Interceptors, Apertor’s robust pipeline is unlocking new treatment possibilities for cancer patients.

Apertor Pharmaceuticals Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Apertor Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Vinh Kenny Thai	Scientist		View
Ericka Mendez	Senior Director, Operations at Apertor Pharmaceuticals	Richmond, California, United States	Email Phone
Edmund Graziani	Chief Executive Officer at Apertor Pharmaceuticals	Alameda, California, United States	Email Phone
Nageswari Yarravarapu, Phd	Senior Scientist at Apertor Pharmaceuticals - Translational Biology - Drug Discovery and Development - Oncology	Fremont, California, United States	Email Phone